World Journal of Surgery

, Volume 31, Issue 5, pp 1055–1065

Coagulopathy: Its Pathophysiology and Treatment in the Injured Patient

  • Brandon H. Tieu
  • John B. Holcomb
  • Martin A. Schreiber


Hemorrhage continues to be one of the leading causes of death following trauma. Trauma patients are susceptible to the early development of coagulopathy and the most severely injured patients are coagulopathic on hospital admission. Hypothermia, acidosis, and dilution from standard resuscitation can worsen the presenting coagulopathy and perpetuate bleeding. Early identification of coagulopathy is dependent on clinical awareness and point of care laboratory values. Routinely used laboratory coagulation parameters fail to adequately describe this state. Thrombelastography is a test that can be done at the bedside and uses whole blood to provide a functional evaluation of coagulation. Rapid diagnosis of coagulopathy, followed by prevention or correction of hypothermia and acidosis should be a priority during the initial evaluation and resuscitation. Judicious use of resuscitation fluids and early replacement of coagulation factors will help prevent iatrogenic hemodilution. This review covers the pathophysiology as well as the clinical and laboratory diagnosis of coagulopathy. Prevention and treatment strategies are discussed, including early transfusion of coagulation factors during massive transfusion and the use of recombinant factor VIIa. Damage control resuscitation is briefly discussed, and it involves the combination of hypotensive resuscitation and hemostatic resuscitation. Finally, a description of the use of fresh whole blood in the military setting is included. Its use has been proven to be safe and beneficial in this setting and warrants further investigation as an adjunct to the management of civilian trauma patients.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Centers for Disease Control and Prevention: Web-based Injury Statistics Query and Reporting System. Atlanta: US Department of Health and Human Services, CDC, National Center for Injury Prevention and Control, 2003Google Scholar
  2. 2.
    Sauaia A, Moore FA, Moore EE, et al. Epidemiology of trauma deaths: a reassessment. J Trauma 1995;38:185–193CrossRefPubMedGoogle Scholar
  3. 3.
    Acosta JA, Yang JC, Winchell RJ, et al. Lethal injuries and time to death in a level I trauma center. J Am Coll Surg 1998;186:528–533CrossRefPubMedGoogle Scholar
  4. 4.
    Stewart RM, Myers JG, Dent DL, et al. Seven hundred fifty-three consecutive deaths in a level I trauma center: the argument for injury prevention. J Trauma 2003;54:66–70; discussion 70–71CrossRefPubMedGoogle Scholar
  5. 5.
    MacLeod JB, Lynn M, McKenney MG, et al. Early coagulopathy predicts mortality in trauma. J Trauma 2003;55:39–44CrossRefPubMedGoogle Scholar
  6. 6.
    Rosenberg RD, Aird WC. Vascular-bed–specific hemostasis and hypercoagulable states. N Engl J Med 1999;340:1555–1564 [Review]CrossRefPubMedGoogle Scholar
  7. 7.
    Esmon CT, Owen WG. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci USA 1981;78:2249–2252CrossRefPubMedGoogle Scholar
  8. 8.
    Hulka F, Mullins RJ, Frank EH. Blunt brain injury activates the coagulation process. Arch Surg 1996;131:923–927PubMedGoogle Scholar
  9. 9.
    Faringer PD, Mullins RJ, Johnson RL, Trunkey DD. Blood component supplementation during massive transfusion of AS-1 red cells in trauma patients. J Trauma 1993;34:481–485; discussion 485–487CrossRefPubMedGoogle Scholar
  10. 10.
    Cosgriff N, Moore EE, Sauaia A, et al. Predicting life-threatening coagulopathy in the massively transfused trauma patient: hypothermia and acidoses revisited. J Trauma 1997;42:857–861; discussion 861–862CrossRefPubMedGoogle Scholar
  11. 11.
    Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma 2003;54:1127–1130CrossRefPubMedGoogle Scholar
  12. 12.
    Weil MH, Afifi AA. Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock). Circulation 1970;41:989–1001PubMedGoogle Scholar
  13. 13.
    Gentilello LM. Practical approaches to hypothermia. In: Maull KI, Cleveland HC, Feliciano DV, et al., editors, Advances in Trauma and Critical Care, vol. 9, St. Louis, Mosby, 1994;39–79Google Scholar
  14. 14.
    Kermode JC, Zheng Q, Milner EP. Marked temperature dependence of the platelet calcium signal induced by human von Willebrand factor. Blood 1999;94:199–207PubMedGoogle Scholar
  15. 15.
    Hess JR, Hiippala S. Optimizing the use of blood products in trauma care. Crit Care 2005;9(Suppl 5):S10–S14CrossRefPubMedGoogle Scholar
  16. 16.
    Ferrara A, MacArthur JD, Wright HK, et al. Hypothermia and acidosis worsen coagulopathy in the patient requiring massive transfusion. Am J Surg 1990;160:515–518CrossRefPubMedGoogle Scholar
  17. 17.
    Johnston TD, Chen Y, Reed RL 2nd. Functional equivalence of hypothermia to specific clotting factor deficiencies. J Trauma 1994;37:413–417CrossRefPubMedGoogle Scholar
  18. 18.
    Meng ZH, Wolberg AS, Monroe DM 3rd, et al. The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients. J Trauma 2003;55:886–891CrossRefPubMedGoogle Scholar
  19. 19.
    Hess JR, Lawson JH. The coagulopathy of trauma versus disseminated intravascular coagulation. J Trauma 2006;60(Suppl 6):S12–S19 [Review]CrossRefPubMedGoogle Scholar
  20. 20.
    Martini WZ, Pusateri AE, Uscilowicz JM, et al. Independent contributions of hypothermia and acidosis to coagulopathy in swine. J Trauma 2005;58:1002–1009; discussion 1009–1010CrossRefPubMedGoogle Scholar
  21. 21.
    Waters JH, Gottlieb A, Schoenwald P, et al. Normal saline versus lactated Ringer’s solution for intraoperative fluid management in patients undergoing abdominal aortic aneurysm repair: an outcome study. Anesth Analg 2001;93:817–822CrossRefPubMedGoogle Scholar
  22. 22.
    Zuckerman L, Cohen E, Vagher JP, et al. Comparison of thrombelastography with common coagulation tests. Thromb Haemost 1981;46:752–756PubMedGoogle Scholar
  23. 23.
    Kaufmann CR, Dwyer KM, Crews JD, et al. Usefulness of thrombelastography in assessment of trauma patient coagulation. J Trauma 1997;42:716–720; discussion 720–722CrossRefPubMedGoogle Scholar
  24. 24.
    Zambruni A, Thalheimer U, Leandro G, et al. Thromboelastography with citrated blood: comparability with native blood, stability of citrate storage and effect of repeated sampling. Blood Coagul Fibrinolysis 2004;15:103–107CrossRefPubMedGoogle Scholar
  25. 25.
    Pivalizza EG, Pivalizza PJ, Gottschalk LI, et al. Celite-activated thrombelastography in children. J Clin Anesth 2001;13:20–23CrossRefPubMedGoogle Scholar
  26. 26.
    Gorton HJ, Warren ER, Simpson NA, et al. Thromboelastography identifies sex-related differences in coagulation. Anesth Analg 2000;91:1279–1281CrossRefPubMedGoogle Scholar
  27. 27.
    Manspeizer HE, Imai M, Frumento RJ, et al. Arterial and venous Thrombelastograph variables differ during cardiac surgery. Anesth Analg 2001;93:277–281CrossRefPubMedGoogle Scholar
  28. 28.
    Camenzind V, Bombeli T, Seifert B, et al. Citrate storage affects Thrombelastograph analysis. Anesthesiology 2000;92:1242–1249CrossRefPubMedGoogle Scholar
  29. 29.
    Vig S, Chitolie A, Bevan DH, et al. Thromboelastography: a reliable test? Blood Coagul Fibrinolysis 2001;12:555–561CrossRefPubMedGoogle Scholar
  30. 30.
    Rajwal S, Richards M, O’Meara M. The use of recalcified citrated whole blood—a pragmatic approach for thromboelastography in children. Paediatr Anaesth 2004;14:656–60CrossRefPubMedGoogle Scholar
  31. 31.
    Gentilello LM, Cobean RA, Offner PJ, et al. Continuous arteriovenous rewarming: rapid reversal of hypothermia in critically ill patients. J Trauma 1992;32:316–325; discussion 325–327CrossRefPubMedGoogle Scholar
  32. 32.
    Gentilello LM, Jurkovich GJ, Stark MS, et al. Is hypothermia in the victim of major trauma protective or harmful? A randomized, prospective study. Ann Surg 1997;226:439–447; discussion 447–449CrossRefPubMedGoogle Scholar
  33. 33.
    Kiraly LN, Differding JA, Enomoto TM, et al. Resuscitation with normal saline (NS) vs. lactated ringers (LR) modulates hypercoagulability and leads to increased blood loss in an uncontrolled hemorrhagic shock swine model. J Trauma 2006;61:57–64; discussion 64–65CrossRefPubMedGoogle Scholar
  34. 34.
    Entholzner EK, Mielke LL, Calatzis AN, et al. Coagulation effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weight. Act Anesth Scand 2000;44:1116–1121CrossRefGoogle Scholar
  35. 35.
    Jamnicki M, Zollinger A, Seifert B, et al. Compromised blood coagulation: an in vitro comparison of hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.5 using thrombelastography. Anesth Analg 1998;87:989–993CrossRefPubMedGoogle Scholar
  36. 36.
    Langeron O, Doelberg M, Ang ET, et al. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg 2001;92:855–862CrossRefPubMedGoogle Scholar
  37. 37.
    Fenger-Eriksen C, Anker-Moller E, Heslop J, et al. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate. Br J Anaesth 2005;94:324–329CrossRefPubMedGoogle Scholar
  38. 38.
    Martin G, Bennett-Guerrero E, Wakeling H, et al. A prospective, randomized comparison of thromboelastographic coagulation profile in patients receiving lactated Ringer’s solution, 6% hetastarch in a balanced-saline vehicle, or 6% hetastarch in saline during major surgery. J Cardiothorac Vasc Anesth 2002;16:441–446CrossRefPubMedGoogle Scholar
  39. 39.
    Gan TJ, Bennett-Guerrero E, Phillips-Bute B, et al. Hextend, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Hextend Study Group. Anesth Analg 1999;88:992–998CrossRefPubMedGoogle Scholar
  40. 40.
    Gross D, Landau EH, Assalia A, et al. Is hypertonic saline resuscitation safe in “uncontrolled” hemorrhagic shock? J Trauma 1988;28:751–756CrossRefPubMedGoogle Scholar
  41. 41.
    Gross D, Landau EH, Klin B, Krausz MM. Quantitative measurement of bleeding following hypertonic saline therapy in “uncontrolled” hemorrhagic shock. J Trauma 1989;29:79–83CrossRefPubMedGoogle Scholar
  42. 42.
    Krausz MM, Landau EH, Klin B, et al. Hypertonic saline treatment of uncontrolled hemorrhagic shock at different periods from bleeding. Arch Surg 1992;127:93–96PubMedGoogle Scholar
  43. 43.
    Reed RL 2nd, Johnston TD, Chen Y, et al. Hypertonic saline alters plasma clotting times and platelet aggregation. J Trauma 1991;31:8–14CrossRefPubMedGoogle Scholar
  44. 44.
    Wilder DM, Reid TJ, Bakaltcheva IB. Hypertonic resuscitation and blood coagulation: in vitro comparison of several hypertonic solutions for their action on platelets and plasma coagulation. Thromb Res 2002;107:255–261CrossRefPubMedGoogle Scholar
  45. 45.
    Watters JM, Tieu BH, Differding JA, et al. A single bolus of 3% hypertonic saline with 6% dextran provides optimal initial resuscitation after uncontrolled hemorrhagic shock. J Trauma 2006;61:75–81CrossRefPubMedGoogle Scholar
  46. 46.
    Kauvar DS, Wade CE. The epidemiology and modern management of traumatic hemorrhage: US and international perspectives. Crit Care 2005;9(Suppl 5):S1–S9CrossRefPubMedGoogle Scholar
  47. 47.
    Cannon W, Frawer J, Cowell E. The preventive treatment of wound shock. JAMA 1918;70:618–621Google Scholar
  48. 48.
    Bickell WH, Wall MJ, Pepe PE, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 1994;331:1105–1109CrossRefPubMedGoogle Scholar
  49. 49.
    NATO Emergency War Surgery Handbook. 2004Google Scholar
  50. 50.
    Dutton RP, Mackenzie CF, Scalea TM. Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma 2002;52:1141–1146CrossRefPubMedGoogle Scholar
  51. 51.
    Holcomb JB. Fluid resuscitation in modern combat casualty care: lessons learned from Somalia. J Trauma 2003;54(Suppl 5):S46–51PubMedGoogle Scholar
  52. 52.
    Carrico CJ, Holcomb JB, Chaudry IH. PULSE Trauma Work Group. Post Resuscitative and Initial Utility of Life Saving Efforts. Scientific Priorities and Strategic Planning for Resuscitation Research and Life Saving Therapy Following Traumatic Injury: Report of the PULSE Trauma Work Group. Acad Emerg Med 2002;9:621–626CrossRefPubMedGoogle Scholar
  53. 53.
    Sondeen JL, Coppes VG, Holcomb JB. Blood pressure at which rebleeding occurs after resuscitation in swine with aortic injury. J Trauma 2003;54(Suppl):S110–117PubMedGoogle Scholar
  54. 54.
    Wade CE, Holcomb JB. Endpoints in clinical trials of fluid resuscitation of patients with traumatic injuries. Transfusion 2005;45:4S–8SCrossRefPubMedGoogle Scholar
  55. 55.
    Lozano ML, Rivera J, Gonzalez-Conejero R, et al. Loss of high-affinity thrombin receptors during platelet concentrate storage impairs the reactivity of platelets to thrombin. Transfusion 1997;37:368–375CrossRefPubMedGoogle Scholar
  56. 56.
    Hirshberg A, Dugas M, Banez EI, et al. Minimizing dilutional coagulopathy in exsanguinating hemorrhage: a computer simulation. J Trauma 2003;54:454–463CrossRefPubMedGoogle Scholar
  57. 57.
    Hewson JR, Neame PB, Kumar N, et al. Coagulopathy related to dilution and hypotension during massive transfusion. Crit Care Med 1985;13:387–391CrossRefPubMedGoogle Scholar
  58. 58.
    Kauvar DS, Holcomb JB, Norris GC, et al. Fresh whole blood transfusion: a controversial military practice. J Trauma 2006;61:181–184CrossRefPubMedGoogle Scholar
  59. 59.
    Mohr R, Goor DA, Yellin A, et al. Fresh blood units contain large potent platelets that improve hemostasis after open heart operations. Ann Thorac Surg 1992;53:650–654PubMedCrossRefGoogle Scholar
  60. 60.
    Martinowitz U, Kenet G, Segal E, et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 2001;51:431–438; discussion 438–439CrossRefPubMedGoogle Scholar
  61. 61.
    Levy JH. Novel pharmacologic approaches to reduce bleeding. Can J Anaesth 2003;50(Suppl 6):S26–30 [Review]PubMedGoogle Scholar
  62. 62.
    Dutton RP, McCunn M, Hyder M, et al. Factor VIIa for correction of traumatic coagulopathy. J Trauma 2004;57:709–718; discussion 718–719CrossRefPubMedGoogle Scholar
  63. 63.
    Boffard KD, Riou B, Warren B, et al. the NovoSeven Trauma Study Group. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005;59:8–15; discussion 15–18CrossRefPubMedGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2007

Authors and Affiliations

  • Brandon H. Tieu
    • 1
  • John B. Holcomb
    • 2
  • Martin A. Schreiber
    • 1
  1. 1.Department of Surgery, Division of Trauma and Critical CareOregon Health & Science UniversityPortlandUSA
  2. 2.Trauma DivisionU.S. Army Institute of Surgical ResearchFort Sam HoustonUSA

Personalised recommendations